NÖK Therapeutics, Inc.
PrivateLast Round
Crowdfunding
Mar 26, 2026
Total Funding Raised
$524,500
Company Overview
NÖK Therapeutics, Inc. is a biotechnology company that develops autologous natural killer (NK) cell-based cancer therapies designed to be administered without lymphodepleting chemotherapy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NÖK Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NÖK Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Mar 26, 2026 | ||||
| Corporate Funding | Dec 23, 2024 |
NÖK Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hilton Family Office | Corporate Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2026
Raised $1.4K in a crowdfunding round.
- Dec 23, 2024
$10M raised with J. Bradley Hilton leading.
NÖK Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NÖK Therapeutics, Inc.'s valuation, stock price, and market status.